Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Specific Aim 1	STARTED	Belimumab	11
Specific Aim 1	STARTED	Placebo	6
Specific Aim 1	COMPLETED	Belimumab	10
Specific Aim 1	COMPLETED	Placebo	6
Specific Aim 1	NOT COMPLETED	Belimumab	1
Specific Aim 1	NOT COMPLETED	Placebo	0
Specific Aim 2	STARTED	Belimumab	11
Specific Aim 2	STARTED	Placebo	6
Specific Aim 2	COMPLETED	Belimumab	10
Specific Aim 2	COMPLETED	Placebo	6
Specific Aim 2	NOT COMPLETED	Belimumab	1
Specific Aim 2	NOT COMPLETED	Placebo	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03244059/flow